期刊文献+

Clinical significance of microRNA-130b in osteosarcoma and its role in cell growth and invasion 被引量:3

Clinical significance of microRNA-130b in osteosarcoma and its role in cell growth and invasion
下载PDF
导出
摘要 Objective: To investigate clinical signii cance of microRNA-130b(mi R-130b) in osteosarcoma and its role in cell growth and invasion. Methods: miR-130b expression was detected in 68 samples of surgically resected osteosarcoma and matched normal tumor-adjacent tissues by q RT-PCR. The expression of miR-130b was altered by corresponding vectors in osteosarcoma cells, and then Western blot was used to detect the expression of PPAR毭. Brd U cell proliferation and Transwell assays were performed to determine cell proliferation and invasion. Results: The expression of miR-130b in osteosarcoma tissues was signii cantly higher than that in normal tumor-adjacent tissues. Its expression in patients with metastasis was signii cantly higher than that in those without metastases. miR-130b expression in tumor tissues was signii cantly associated with tumor size, clinical stage and distant metastasis. And its expression was signii cantly correlated with overall survival and disease free survival. miR-130b overexpression obviously repressed the expression of PPAR毭, and resulted in signii cant increase of Saos-2 cell proliferation and invasion. On the contrast, repressing miR-130b expression with its inhibitor signii cantly increased PPAR毭 expression, and inhibited MG-63 cell proliferation and invasion. Conclusions: The high-expression of miR-130b is correlated with the adverse clinicopathological features and poor prognosis in osteosarcoma. miR-130b may regulate proliferation and invasion of osteosarcoma cells by targeting PPAR毭, suggesting miR-130b may play a key role in the progression of osteosarcoma. Objective: To investigate clinical signii cance of microRNA-130b(mi R-130b) in osteosarcoma and its role in cell growth and invasion. Methods: mi R-130 b expression was detected in 68 samples of surgically resected osteosarcoma and matched normal tumor-adjacent tissues by q RT-PCR. The expression of mi R-130 b was altered by corresponding vectors in osteosarcoma cells, and then Western blot was used to detect the expression of PPAR毭. Brd U cell proliferation and Transwell assays were performed to determine cell proliferation and invasion. Results: The expression of mi R-130 b in osteosarcoma tissues was signii cantly higher than that in normal tumor-adjacent tissues. Its expression in patients with metastasis was signii cantly higher than that in those without metastases. mi R-130 b expression in tumor tissues was signii cantly associated with tumor size, clinical stage and distant metastasis. And its expression was signii cantly correlated with overall survival and disease free survival. mi R-130 b overexpression obviously repressed the expression of PPAR毭, and resulted in signii cant increase of Saos-2 cell proliferation and invasion. On the contrast, repressing mi R-130 b expression with its inhibitor signii cantly increased PPAR毭 expression, and inhibited MG-63 cell proliferation and invasion. Conclusions: The high-expression of mi R-130 b is correlated with the adverse clinicopathological features and poor prognosis in osteosarcoma. mi R-130 b may regulate proliferation and invasion of osteosarcoma cells by targeting PPAR毭, suggesting mi R-130 b may play a key role in the progression of osteosarcoma.
出处 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2015年第9期737-741,共5页 亚太热带医药杂志(英文版)
关键词 microRNA-130b OSTEOSARCOMA TUMOR growth INVASION CLINICAL SIGNIFICANCE microRNA-130b Osteosarcoma Tumor growth Invasion Clinical significance
  • 相关文献

参考文献20

  • 1Vincenza Leone,Concetta Langella,Daniela D’Angelo,Paula Mussnich,Anne Wierinckx,Luigi Terracciano,Gerald Raverot,Joel Lachuer,Sandra Rotondi,Marie-Lise Jaffrain-Rea,Jacqueline Trouillas,Alfredo Fusco.miR-23b and miR-130b expression is downregulated in pituitary adenomas[J]. Molecular and Cellular Endocrinology . 2014 (1-2)
  • 2Anna-Regina Scheffer,Stefan Holdenrieder,Glen Kristiansen,Alexander Ruecker,Stefan C. Müller,J?rg Ellinger.Circulating microRNAs in serum: novel biomarkers for patients with bladder cancer?[J]. World Journal of Urology . 2014 (2)
  • 3J.B. Kjersem,T. Ikdahl,O.C. Lingjaerde,T. Guren,K.M. Tveit,E.H. Kure.Plasma microRNAs predicting clinical outcome in metastatic colorectal cancer patients receiving first-line oxaliplatin-based treatment[J]. Molecular Oncology . 2014 (1)
  • 4Ron Rabinowicz,Micha Barchana,Irena Liphshiz,Shai Linn,Boris Futerman,Myriam Weyl Ben-Arush.Cancer Incidence and Survival Among Infants in Israel, 1998–2007[J]. Pediatric Hematology-Oncology . 2013 (7)
  • 5Bi-Lan Li,Cong Lu,Wen Lu,Ting-ting Yang,Junjie Qu,Xiayu Hong,Xiao-ping Wan.miR-130b is an EMT-related microRNA that targets DICER1 for aggression in endometrial cancer[J]. Medical Oncology . 2013 (1)
  • 6Michael Sand,Marina Skrygan,Daniel Sand,Dimitrios Georgas,Thilo Gambichler,Stephan A. Hahn,Peter Altmeyer,Falk G. Bechara.Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi[J]. Cell and Tissue Research . 2013 (1)
  • 7Ramiro Garzon,Guido Marcucci.Potential of microRNAs for cancer diagnostics, prognostication and therapy[J]. Current Opinion in Oncology . 2012 (6)
  • 8Baek‐Hui Kim,Soon Won Hong,Aeree Kim,Seung Ho Choi,Sun Och Yoon.Prognostic implications for high expression of oncogenic microRNAs in advanced gastric carcinoma[J]. J. Surg. Oncol. . 2012 (5)
  • 9Yi W Kong,David Ferland-McCollough,Thomas J Jackson,Martin Bushell.microRNAs in cancer management[J]. Lancet Oncology . 2012 (6)
  • 10Phillip A. Letourneau,Lianchun Xiao,Matthew T. Harting,Kevin P. Lally,Charles S. Cox,Richard J. Andrassy,Andrea A. Hayes-Jordan.Location of pulmonary metastasis in pediatric osteosarcoma is predictive of outcome[J]. Journal of Pediatric Surgery . 2011 (7)

共引文献9

同被引文献26

  • 1Sugihara H,Ishimoto T,Miyake K,etal.Noncoding RNA Expression Aberration Is Associated with Cancer Progression and Is a Potential Biomarker in Esophageal Squamous Cell Carcinoma. Int J Mol Sci . 2015
  • 2Yonghua Han,Yuchen Liu,Yaoting Gui,Zhiming Cai.??Long intergenic non‐coding RNA TUG1 is overexpressed in urothelial carcinoma of the bladder(J)J. Surg. Oncol. . 2012 (5)
  • 3Qu J,Li M,Zhong W,Hu C.Competing endogenous RNA in cancer:a new pattern of gene expression regulation. Int J Clin Exp Med . 2015
  • 4Paraskevopoulou MD,Hatzigeorgiou AG.Analyzing MiR NA-LncR NAInteractions. Methods in Molecular Biology . 2016
  • 5Jiemei Tan,Kaifeng Qiu,Mingyi Li,Ying Liang.??Double-negative feedback loop between long non-coding RNA TUG1 and miR-145 promotes epithelial to mesenchymal transition and radioresistance in human bladder cancer cells(J)FEBS Letters . 2015 (20)
  • 6Xiaotian Zhang,Jianming Xu,Huilong Liu,Lin Yang,Jun Liang,Nong Xu,Yuxian Bai,Jiejun Wang,Lin Shen.??Predictive biomarkers for the efficacy of cetuximab combined with cisplatin and capecitabine in advanced gastric or esophagogastric junction adenocarcinoma: a prospective multicenter phase 2 trial(J)Medical Oncology . 2014 (10)
  • 7Emre ?zgür,Ufuk Mert,Mustafa Isin,Murat Okutan,Nejat Dalay,Ugur Gezer.??Differential expression of long non-coding RNAs during genotoxic stress-induced apoptosis in HeLa and MCF-7 cells(J)Clinical and Experimental Medicine . 2013 (2)
  • 8S. Akiyoshi,T. Fukagawa,H. Ueo.Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. British Journal of Cancer . 2012
  • 9Trotter K,Schneider SM,Turner BS.Group appointments in a breast cancer survivorship clinic. J Adv Pract Oncol . 2013
  • 10Mc Gill MR,Jaeschke H.Micro RNAs as signaling mediators and biomarkers of drug-and chemical-induced liver injury. J Clin Med . 2015

引证文献3

二级引证文献25

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部